US$ 22.88
is allulose a glp-1 agonist and GLP-1: Potential Benefits and Evidence The GLP-1 Revolution: What Patients
Description
As neurological and medical complications after stroke are not properly predicted, prevented, or dealt with, they are considered to constitute the main cause of the high morbidity and mortality associated with strokes (78)
Therefore, GLP-1R agonists are promising agents for the treatment of obese individuals

2019;17(4):e05668

13 , 15 Although the magnitude of this effect in clinical settings remains unclear, there is a biological rationale to consider an elevated risk of volume-related symptoms in susceptible individuals, such as older adults, those with orthostatic hypotension, or patients on multidrug antihypertensive regimens

Keep in mind that these medications should be used alongside other lifestyle modifications, including changes to your diet and regular physical activity
